Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 8/20 | 0.74 |
| ▸ | LSS | P48449 | 3/20 | 0.58 |
| ▸ | ACHE | P22303 | 6/20 | 0.57 |
| ▸ | BCHE | P06276 | 5/20 | 0.57 |
| ▸ | PPARA | Q07869 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12748152 | 0.91 | LTA4H (0.62) | LTA4HLSSACHEBCHEPPARA | |
| SCHEMBL12748157 | 0.90 | LTA4H (0.61) | LTA4HLSSACHEBCHEPPARA | |
| SCHEMBL12748065 | 0.90 | LTA4H (0.61) | LTA4HLSSACHEBCHEPPARA | |
| SCHEMBL9772499 | 0.90 | LTA4H (0.81) | LTA4H | |
| SCHEMBL1469807 | 0.87 | LTA4H (0.76) | LTA4HLSSACHEBCHEPPARA | |
| SCHEMBL7139497 | 0.85 | LTA4H (1.00) | LTA4H | |
| SCHEMBL12795298 | 0.85 | LSS (0.58) | LTA4HLSSACHEBCHEPPARA | |
| SCHEMBL12748064 | 0.85 | LTA4H (0.55) | LTA4HLSSACHEBCHEPPARA | |
| SCHEMBL13579103 | 0.84 | ACHE (0.67) | LTA4HLSSACHEBCHEPPARA | |
| SCHEMBL25540208 | 0.84 | LTA4H (0.73) | LTA4HL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8362101-B2 | Multifunctional type II photoinitiators and curable compositions | AGFA GRAPHICS NV (BE) | 2013-01-29 | — | — | US | disclosed |
| US-8362101-B2 | Multifunctional type II photoinitiators and curable compositions | AGFA GRAPHICS NV (BE) | 2013-01-29 | — | — | US | disclosed |
| US-8362101-B2 | Multifunctional type II photoinitiators and curable compositions | AGFA GRAPHICS NV (BE) | 2013-01-29 | — | — | US | disclosed |
| US-20110069130-A1 | MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-03-24 | — | — | US | disclosed |
| US-20110069130-A1 | MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-03-24 | — | — | US | disclosed |
| US-20110069130-A1 | MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-03-24 | — | — | US | disclosed |
| WO-2009147054-A1 | MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2009-12-10 | — | — | WO | disclosed |
| EP-2130818-A1 | Multifunctional Type II photoinitiators and curable compositions | AGFA Graphics NV (BE) | 2009-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110069130-A1 | MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | CRKL, CYTH2, CCNH | LTA4H 507/4885LSS 1685/4885ACHE 3085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.